Page 56 - GTM-2-3
P. 56

Global Translational Medicine                                           Deep learning by NMR-biochemical



               imaging: An evidence-based analysis.  Ont Health Technol   61.  Kondo DG, Sung YH, Hellem TL, et al., 2011, Open-label
               Assess Ser, 6: 1–79.                               adjunctive creatine for female adolescents with SSRI-
                                                                  resistant major depressive disorder: A  31-phosphorus
            52.  Kettelhack  C,  Wickede  MV,  Vogl  T,  et al., 2002,
               31Phosphorus-magnetic resonance spectroscopy to assess   magnetic resonance spectroscopy study.  J  Affect Disord,
               histologic tumor response noninvasively after isolated limb   135: 354–361.
               perfusion for soft tissue tumors. Cancer, 94: 1557–1564.      https://doi.org/10.1016/j.jad.2011.07.010
               https://doi.org/10.1002/cncr.10361              62.  Ramesh K, Mellon EA, Gurbani SS, et al., 2022, A multi-
                                                                  institutional pilot clinical trial of spectroscopic MRI-guided
            53.  de  Fátima  Vasco  Aragão  M,  Otaduy  MCG,  de  Melo  RV,
               et al., 2007, Multivoxel spectroscopy with short echo time:   radiation dose escalation for newly diagnosed glioblastoma.
               Choline/N-acetyl-aspartate ratio and the grading of cerebral   Neurooncol Adv, 4: vdac006.
               astrocytomas. Arq Neuropsiquiatr, 65: 286–294.      https://doi.org/10.1093/noajnl/vdac006
               https://doi.org/10.1590/s0004-282x2007000200019  63.  Caivano R, Lotumolo A, Rabasco P,  et  al., 2013, 3 Tesla
                                                                  magnetic resonance spectroscopy: Cerebral gliomas vs.
            54.  Kallén  K,  Burtscher  IM,  Holtås  S,  2000,  201Thallium
               SPECT and 1H-MRS compared with MRI in chemotherapy   metastatic brain tumors. Our experience and review of the
               monitoring of high-grade malignant astrocytomas.   literature. Int J Neurosci, 123: 537–543.
               J Neurooncol, 46: 173–185.                         https://doi.org/10.3109/00207454.2013.774395
               https://doi.org/10.1023/a:1006429329677         64.  Sharma  R,  Narayana  PA,  Wolinsky  JS,  2001,  Grey  matter
                                                                  abnormalities in multiple sclerosis: Proton magnetic
            55.  Urdzik J, Bjerner T, Wanders A, et al., 2012, The value of
               pre-operative magnetic resonance spectroscopy in the   resonance spectroscopic imaging. Mult Scler, 7: 221–226.
               assessment of steatohepatitis in patients with colorectal liver      https://doi.org/10.1177/135245850100700402
               metastasis. J Hepatol, 56: 640–646.
                                                               65.  Bedell BJ, Narayana PA, Johnston DA, 1996, 3‑dimensional
               https://doi.org/10.1016/j.jhep.2011.10.006         MR image registration of the human brain. Magn Reson
                                                                  Med, 35: 384–390.
            56.  Watanabe  T,  Shiino  A,  Akiguchi  I,  2008,  Absolute
               quantification in proton magnetic resonance spectroscopy is      https://doi.org/10.1002/mrm.1910350317
               superior to relative ratio to discriminate Alzheimer’s disease   66.  Shoeibi A, Khodatars M, Jafari M, et al., 2021, Applications
               from  Binswanger’s  disease.  Dement Geriatr Cogn Disord,   of deep learning techniques for automated multiple sclerosis
               26: 89–100.
                                                                  detection using magnetic resonance imaging: A  review.
               https://doi.org/10.1159/000144044                  Comput Biol Med. 136: 104697.
            57.  Wallström J, Geterud K, Kohestani K, et al., 2021, Prostate      https://doi.org/10.1016/j.compbiomed.2021.104697
               cancer screening with magnetic resonance imaging: Results   67.  Centers for Medicare & Medicaid Services (CMS), 2004,
               from  the  second  round  of  the  göteborg  prostate  cancer   Decision Memo for Magnetic Resonance Spectroscopy for
               screening 2 trial. Eur Urol Oncol, 5: 54–60.
                                                                  Brain Tumors (CAG‑00141N). Baltimore, MD: CMS.
               https://doi.org/10.1016/j.euo.2021.09.001
                                                               68.  Ustymowicz A, Tarasow E, Zajkowska J, et al., 2004, Proton
            58.  Schmuecking M, Boltze C, Geyer H, et al., 2009, Dynamic   MR spectroscopy in neuroborreliosis: A preliminary study.
               MRI and CAD vs. choline MRS: Where is the detection level   Neuroradiology, 46: 26–30.
               for a lesion characterisation in prostate cancer? Int J Radiat      https://doi.org/10.1007/s00234-002-0851-6
               Biol, 85: 814–824.
                                                               69.  Hollingworth W, Medina LS, Lenkinski RE,  et al., 2006,
               https://doi.org/10.1080/09553000903090027
                                                                  A systematic literature review of magnetic resonance
            59.  Bongiovanni A, Foca F, Oboldi D, et al., 2022, 3-T magnetic   spectroscopy for the characterization of brain tumors. AJNR
               resonance-guided high-intensity focused ultrasound (3   Am J Neuroradiol, 27: 1404–1411.
               T-MR-HIFU) for the treatment of pain from bone metastases   70.  Hallahan BP, Daly EM, Simmons A, et al., 2012, Fragile X
               of solid tumors. Support Care Cancer, 30: 5737–5745.
                                                                  syndrome: A pilot proton magnetic resonance spectroscopy
               https://doi.org/10.1007/s00520-022-06990-y         study in premutation carriers. J Neurodev Disord, 4: 23.
            60.  Kaufman  MJ,  Henry  ME,  Frederick  BB,  et al., 2003,      https://doi.org/10.1186/1866-1955-4-23
               Selective serotonin reuptake inhibitor discontinuation   71.  Zakian  KL,  Sircar  K,  Hricak  H,  et al.,  2005,  Correlation
               syndrome is associated with a rostral anterior cingulate   of  proton  MR  spectroscopic  imaging  with  Gleason  score
               choline metabolite decrease: A proton magnetic resonance   based on step-section pathologic analysis after radical
               spectroscopic imaging study. Biol Psychiatry, 54: 534–539.
                                                                  prostatectomy. Radiology, 234: 804–814.
               https://doi.org/10.1016/s0006-3223(02)01828-0
                                                                  https://doi.org/10.1148/radiol.2343040363

            Volume 2 Issue 3 (2023)                         24                        https://doi.org/10.36922/gtm.337
   51   52   53   54   55   56   57   58   59   60   61